Corteva
$78.71
▼ -11.90%
−$10.63
$78.71
▼ -11.90% · −$10.63 today
today's move
▼ -11.9%−$10.63
Corteva plunges 12% on Q2 miss and lowered guidance
highThe company missed revenue and earnings estimates and cut its full-year EBITDA outlook, citing weak crop protection demand and farmer spending. This triggered analyst downgrades and a sharp sell-off despite a broader market rally.
Operating record
Capital structure
Valuation
Forward P/E
Price against expected earnings
Needs attention · 48% above Sector avg
19.92x
Price / sales
Value assigned to each sales dollar
Strong · Under 3x annual sales
2.95x
Price / FCF
Price against free cash generation
Rich · Above 35x free cash flow
83.49x
EV / EBITDA
Operating value including debt
Reasonable · Between 12x and 22x EBITDA
13.48x
Quality
ROIC
Return earned on invested capital
Weak · Below 8% return on capital
7.8%
ROE
Profit generated from shareholder equity
Needs attention · Among weakest in sector
4.3%
Debt / equity
Balance-sheet leverage
Favorable · Exceptional vs sector peers
0.19x
Current ratio
Short-term assets against liabilities
Strong · Comfortable short-term liquidity
1.52x
Selected financial data sourced from StockAnalysis and refreshed weekly. Figures may be delayed and are for research context, not investment advice.
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| $52.64B | 52.0 | +3.7% | 52 | |
| $98.74B | 11.8 | +25.2% | 83 | |
| $9.47B | 20.3 | +66.3% | 81 | |
| $4.43B | 13.4 | +7.5% | 76 | |
| $90.03B | 30.8 | +0.2% | 70 |
US stock research
Corteva trades on NYSE under the ticker CTVA. This page brings the latest available price, returns, valuation, growth, analyst context, earnings dates, and relevant headlines into one research view. Use the timestamp to distinguish current market data from slower-moving fundamentals.
Market snapshot updated Jul 31, 2026, 7:59 PM UTC.